Registry for understanding chronic subdural hematoma
Official title: Registry of Chronic Subdural Hematoma
Run by Erasmus Medical Center · NCT06759428 · Data updated 2026-11-12
This study is looking to gather information from adults with chronic subdural hematoma to see how different treatments work and improve care for future patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1500 (estimated) |
| Sponsor | Erasmus Medical Center Academic / other |
| Locations | 2 sites (Amsterdam and 1 other locations) |
| Status | Recruiting |
| Started | October 1, 2021 |
| Main results expected | October 2027 |
| Study ends | January 2028 |
| Registry record updated | January 7, 2025 |
| Trial ID | NCT06759428 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who have been diagnosed with chronic subdural hematoma.
✕Probably not a fit
Patients who do not consent to participate in the registry will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to gather detailed information on chronic subdural hematoma (CSDH) by examining patient characteristics at diagnosis, treatment strategies employed, and outcomes following treatment. It will involve adult patients diagnosed with CSDH who will receive standard care and participate in a follow-up telephone interview three months post-treatment. The study seeks to address variability in management practices and improve evidence-based guidelines for CSDH treatment.
Why it matters
Potential benefit: If successful, this study could enhance understanding of CSDH management and improve patient outcomes through better-informed treatment guidelines.
How similar studies have gone: While there is ongoing research in the field, this registry approach is novel in its focus on observational data collection for CSDH management.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with CSDH * 18 years or older Exclusion Criteria: * Patients who do not consent to participate in the registry
Where it's running
-
Amsterdam UMC
Amsterdam, Netherlands Recruiting -
Erasmus MC
Rotterdam, Netherlands Recruiting
Study contacts
- Principal investigator: Ruben Dammers — Erasmus Medical Center
- Study coordinator: Rahman Fakhry
- Email: r.fakhry@erasmusmc.nl
- Phone: +31 10 7043507
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Middle Meningeal Artery Embolisation to Prevent Recurrence of Chronic Subdural Hematoma
This study tests whether embolising the middle meningeal artery around the time of hematoma evacuation can reduce recurrence in adults with chronic subdural hematoma.
-
What causes vulnerability in older adults with serious diseases and how it affects care decisions
This study tests how often vulnerability factors appear in older adults with serious illnesses and how these factors influence treatment timing, survival, and quality of life.
-
Coil embolization for unilateral vs bilateral chronic subdural hematomas
This trial tests whether unilateral or bilateral coil-based embolization of the middle meningeal artery helps people with chronic subdural hematoma.
-
Non-Thermal Plasma Used During Surgery to Help Prevent Recurrent Chronic Subdural Hematoma
A randomized trial tests whether applying non-thermal plasma during standard surgery to drain a chronic subdural hematoma can reduce recurrence within 6 months.
-
Enhanced recovery pathway for burr-hole drainage in chronic subdural hematoma patients
This project tests whether an enhanced recovery protocol for adults having burr-hole drainage for chronic subdural hematoma can reduce recurrence and complications compared with past patients.
-
Matched microcatheter and guidewire use for middle meningeal artery embolization in chronic subdural hematoma
This will test whether using a matched Aristotle 14 guidewire and Plato 17 microcatheter during middle meningeal artery embolization works better than surgeons' usual device choices for adults with chronic subdural hematoma.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.